Log in to save to my catalogue

Galcanezumab effectiveness on comorbid cluster headache and chronic migraine: a prospective case ser...

Galcanezumab effectiveness on comorbid cluster headache and chronic migraine: a prospective case ser...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2577735686

Galcanezumab effectiveness on comorbid cluster headache and chronic migraine: a prospective case series

About this item

Full title

Galcanezumab effectiveness on comorbid cluster headache and chronic migraine: a prospective case series

Publisher

Cham: Springer International Publishing

Journal title

Neurological sciences, 2022-01, Vol.43 (1), p.697-703

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Background
Cluster headache (CH) and migraine are recurrent painful primary cephalalgies, typically with different clinical appearance and some shared features, such as unilateral pain, common triggers and response to triptans and/or monoclonal antibodies against the calcitonin gene-related peptide (CGRP) pathway. Common pathophysiological mecha...

Alternative Titles

Full title

Galcanezumab effectiveness on comorbid cluster headache and chronic migraine: a prospective case series

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2577735686

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2577735686

Other Identifiers

ISSN

1590-1874

E-ISSN

1590-3478

DOI

10.1007/s10072-021-05624-1

How to access this item